| 5.1299 -0.14 (-2.66%) | 04-25 13:10 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.08  |
1-year : | 6.36 |
| Resists | First : | 5.2 |
Second : | 5.44 |
| Pivot price | 5.11 |
|||
| Supports | First : | 4.82 |
Second : | 4.01 |
| MAs | MA(5) : | 5.18  |
MA(20) : | 5.14 |
| MA(100) : | 5.7 |
MA(250) : | 6.62 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 58.9 |
D(3) : | 57.5 |
| RSI | RSI(14): 49 |
|||
| 52-week | High : | 10.19 | Low : | 4.82 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MTLS ] has closed below upper band by 47.0%. Bollinger Bands are 20.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.36 - 5.38 | 5.38 - 5.39 |
| Low: | 5.11 - 5.13 | 5.13 - 5.15 |
| Close: | 5.23 - 5.27 | 5.27 - 5.3 |
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Thu, 25 Apr 2024
Materialise NV Faces Revenue Dip with Resilient Margins in Q1 2024 - TipRanks.com - TipRanks
Thu, 25 Apr 2024
Materialise NV Posts Mixed Q1 2024 Financials - TipRanks.com - TipRanks
Thu, 25 Apr 2024
Materialise Reports First Quarter 2024 Results - Business Wire
Wed, 24 Apr 2024
Materialise stock gets Overweight rating on strong presence By Investing.com - Investing.com Nigeria
Wed, 24 Apr 2024
Materialise (NASDAQ:MTLS) Earns Overweight Rating from Analysts at Cantor Fitzgerald - MarketBeat
Sun, 21 Apr 2024
Materialise NV's (NASDAQ:MTLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The ... - Yahoo Movies Canada
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 59 (M) |
| Shares Float | 25 (M) |
| Held by Insiders | 3.9 (%) |
| Held by Institutions | 16.1 (%) |
| Shares Short | 80 (K) |
| Shares Short P.Month | 103 (K) |
| EPS | 0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.01 |
| Profit Margin | 2.6 % |
| Operating Margin | 12.7 % |
| Return on Assets (ttm) | 2.3 % |
| Return on Equity (ttm) | 2.8 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 4.33 |
| EBITDA (p.s.) | 0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 20 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | 42.79 |
| PEG Ratio | 0.3 |
| Price to Book value | 1.28 |
| Price to Sales | 1.18 |
| Price to Cash Flow | 15.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|